Reverse Vaccinology to Inform Vaccine Design

Friday, 13 February 2015: 1:00 PM-2:30 PM
Room 210EF (San Jose Convention Center)
Jeffrey Ulmer, Novartis, Siena, United Kingdom
Advances in genetics and bioinformatics have been exploited by Dr Rappuoli to sequence a pathogenís genome and screen for vaccine targets using bioinformatics. First used to develop Serogroup B meningococcus, which stopped a devastating epidemic in New Zealand, Dr Rappuoli has pioneered reverse vaccinology and is applying this method to other elusive bacterial vaccines.